12-Month Stability of Diurnal IOP Control on Cosopt

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the stability of diurnal intraocular pressure in eyes with glaucoma treated with Cosopt

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: West Virginia University
• Treatments: Dorzolamide; Timolol

Criteria

Inclusion Criteria:

• bilateral open-angle glaucoma

Exclusion Criteria:

• contraindications to Cosopt

• pathology affecting tonometry